Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted tetralins as selective estrogen receptor-β agonists

Substituted tetralins as selective estrogen receptor-β agonists

US Patent 8093302 · Granted Jan 10, 2012

Estimated economic value: $65,439,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dihydropyrido pyrimidine compounds as autotaxin inhibitors2017
Imidazo pyridine compounds2016
Bicyclic pyrimidine compounds2015
Imidazole derivatives useful for the treatment of arthritis2014
Substituted benzopyrans as selective estrogen receptor-beta agonists2010
Substituted benzopyrans as selective estrogen receptor-beta agonists2009
Substituted benzopyrans as selective estrogen receptor-beta agonists2008
Substituted benzopyrans as selective estrogen receptor-beta agonists2008
Substituted benzopyrans as selective estrogen receptor-beta agonists2007
Substituted benzopyrans as selective estrogen receptor-beta agonists2007
Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase in2006
Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-li2005